PRIME CELLULAR INC
NT 10-Q, 1997-01-14
NON-OPERATING ESTABLISHMENTS
Previous: MONTGOMERY FUNDS I, 497, 1997-01-14
Next: DMX INC, 10-K, 1997-01-14




<TABLE>
<CAPTION>
<S>                                                                                                 <C>
                                                                                                    -----------------------------
                                                     UNITED STATES                                          OMB APPROVAL
                                           SECURITIES AND EXCHANGE COMMISSION                       -----------------------------
                                                Washington, D.C. 20549                              OMB Number:         3235-0058
                                                                                                    Expires:        June 30, 1994
                                                                                                    Estimated average burden
                                                      FORM 12b-25                                   hours per response ..... 2.50
                                                                                                    -----------------------------
                                                                                                    -----------------------------
                                             NOTIFICATION OF LATE FILING                                    SEC FILE NUMBER

(Check One):  |_| Form 10-K |_| Form 20-F |_| Form 11-K |x| Form 10-Q |_| Form N-SAR                -----------------------------
                                                                                                    -----------------------------
                                                                                                             CUSIP NUMBER

     For Period Ended:  November 30, 1996                                                             -----------------------------
     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR
     For the Transition Period Ended: ___________________________________________________________________________________________

- ------------------------------------------------------------------------------------------------------------------------------------
                            Read Instruction (on back page) Before Preparing Form. Please Print or Type.

         Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
- ------------------------------------------------------------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

This notification relates to Items 10, 11, 12 and 13 of Part IV of the Annual Report on Form 10-K for the year ended January
31, 1996.
____________________________________________________________________________________________________________________________________

PART I -- REGISTRANT INFORMATION

PRIME CELLULAR INC.
Full Name of Registrant

____________________________________________________________________________________________________________________________________
Former Name if Applicable


100 First Stamford Place
Address of Principal Executive Office (Street and Number)


Stamford, CT 06902
City, State and Zip Code

PART II -- RULES 12b-25(b) and (c)

If the subject report could not be filed without  unreasonable  effort or expense and the registrant  seeks relief  pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)

         (a) The reasons  described in  reasonable  detail in Part III of this form could not be  eliminated  without  unreasonable
             effort or expense;
        
  |x|    (b) The subject annual report,  semi-annual  report,  transition  report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR,
             or portion thereof, will be filed on or before the fifteenth calendar day following the  prescribed  due date;  or the
             subject  quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before  the  fifth
             calendar day following the prescribed due date; and
        
         (c) The accountant's  statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail why the Form 10-K, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be
filed within the prescribed time period. (Attach Extra Sheets if Needed)

     The Form 10-Q could not be filed within the prescribed  time period due to unforeseen  difficulties  arising in connection with
     its preparation.
                                                                                                     

                                                                                                                     SEC 1344 (6/94)
</TABLE>



<PAGE>

<TABLE>
<CAPTION>

PART IV--OTHER INFORMATION

<C> <S>                                                                             
(1) Name and telephone number of person to contact in regard to this notification
     
             Robert A. Reinhart                                516                                    496-9033
                  (Name)                                    (Area Code)                             (Telephone Number)

(2) Have all other periodic reports required under Section  13 or 15(d) of  the Securities Exchange Act of
    1934 or Section 30  of the  Investment  Company Act of 1940 during the preceding 12 months (or for such 
    shorter)  period that  the  registrant was required to file such reports been filed? If answer is no,  
    identify report(s).                                                                                       |x| Yes  |_| No
    --------------------------------------------------------------------------------------------------------------------------------

(3) Is it anticipated that any significant change in results of operations from the corresponding period
    for that last fiscal year will be reflected by the earnings  statements to be included in the subject                      
    report or portion thereof?                                                                                |x| Yes  |_| No  
    
    If so, attach an explanation of the anticipated  change,  both narratively and  quantitatively,  and, if appropriate,  state the
    reasons why a reasonable estimate of the results cannot be made.

On June 11, 1996 a wholly-owned  subsidiary of the Compny acquired,  by merger, Bern Associates,  Inc., a Delaware corporaton.  As a
result of the combined  operations  realized by the merger, the Company  anticipates  significant changes to its second quarter 1997
statement of earnings as compared to the second quarter 1996.

====================================================================================================================================


                                                     PRIME CELLULAR INC.
                                            (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date January 14, 1997                                                        By /s/ Robert A. Reinhart
                                                                                -------------------------
                                                                                Robert A. Reinhart, CFO

INSTRUCTION:  The form may be signed by an executive officer of the registrant or by any other duly authorized  representative.  The
name and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf
of the registrant by an authorized representative (other than an executive officer), evidence of the representative's  authority to
sign on behalf of the registrant shall be filed with the form.

- ----------------------------------------------------------- ATTENTION --------------------------------------------------------------
             Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
- ------------------------------------------------------------------------------------------------------------------------------------


                                                        GENERAL INSTRUCTIONS

1.  This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities  Exchange Act
    of 1934.

2.  One signed original and four conformed copies of this form and amendments thereto must be completed and filed with the
    Securities and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and Regulations
    the Act. The information contained in or filed with the form will be made a matter of public record in the Commission files.

3.  A manually  signed copy of the form and amendments  thereto shall be filed with each national  securities  exchange on which any
    class of securities of the registrant is registered.

4.  Amendments  to the  notifications  must also be filed on form 12b-25 but need not restate  information  that has been  correctly
    furnished. The form shall be clearly identified as an amended notification.


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission